FlyBlast

FlyBlast builds technologies to unlock the potential of insect protein and cultivated meat at scale.

Exploring the frontier of insect bioconversion and cultivated meat at scale

FlyBlast aimed to transform food systems by unlocking the potential of insect bioconversion—specifically using genetically enhanced Black Soldier Fly (BSF)—and by lowering the cost barriers in cultivated meat production. The team envisioned a future where underutilized organic side-streams could be transformed into high-value proteins, lipids, and frass, and where cultivated meat could become a competitive, sustainable alternative to traditional animal products.

Their scientific achievements were remarkable. Led by Paul Mozdziak, FlyBlast created three transgenic BSF lines, including one that expressed human insulin, in just over a year, showcasing the power of fast, cost-efficient genetic modification.

Insect bioconversion 2.0 with Black Soldier Flies

The Black Soldier Fly’s scientific name is Hermetia illucens, but the industry calls it “BSF”.
The BSF is not considered a pest, it is safe to breed in Europe, and it does not transmit disease. It is therefore an ideal candidate for large-scale insect farming.
In fact, the BSF is widely recognized as one of the most sustainable sources of protein in the world.

We tried

Unfortunately, FlyBlast had to file for bankruptcy mid 2025. We’re proud to have supported a team that wasn’t afraid to challenge conventional limits and pursue transformative science with conviction and speed.

FlyBlast ventured into high-risk, high-innovation territory and delivered groundbreaking insights that pushed the boundaries of what’s possible in insect biotechnology.

“The Black Soldier Fly can be genetically modified very fast and at relatively low cost. There will be groundbreaking applications from transgenic BSF in many sectors. But it will be without FlyBlast.”

Johan Jacobs